跳至主要内容
临床试验/NCT03632499
NCT03632499已完成不适用

From Research to Clinical Practice. Applying an Algorithm for Prognosis of Upper Limb Paresis in Patients With Subacute Stroke

University of Aarhus1 个研究点 分布在 1 个国家目标入组 103 人开始时间: 2018年6月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
103
试验地点
1
主要终点
Action Research Arm test

研究概览

简要总结

Aim study 1:Assess the accuracy of PREP2 when applied in a subacute rehabilitation setting.

Aim study 2: Prediction of real life UL use. Method: A prospective cohort study. Main outcome measure study 1: Action Research Arm Test (ARAT), measuring UL motor function.

Main outcome study 2: use ratio between affected and unaffected UL measured by accellerometer.

Secondary outcome measure: Fugl-Meyer Motor Assessment for UL (FM).

详细描述

Background Accurate prediction of recovery of UL function after stroke can lead to targeted rehabilitation. The Predict Recovery Potential (PREP2) algorithm combines individual prediction of UL function with recommendations for treatment. The PREP2 algorithm is based on clinical assessment of UL paresis combined with transcranial magnetic stimulation (TMS) to examine corticospinal tract integrity. For this PhD project the PREP2 is modified to be applicable in a rehabilitation setting and the initial assessment of PREP2, the SAFE score, is carried out at day 14.

Study 1 Aim: Assess the accuracy of PREP2 when applied in a subacute rehabilitation setting.

Hypothesis: PREP2 applied at day 14 post stroke accurately predicts UL function 3 months after stroke for a minimum of 75 % of the patients.

Method: A prospective cohort study. Setting and population: The study will take place at Hammel Neurorehabilitation Centre and University Research Clinic. Ninety patients will be included.

Inclusion criteria: First or recurrent ischemic or hemorrhagic stroke (diagnosis verified by CT or MR scan); New upper limp impairment; Less than 15 days post stroke; ≥ 18 years; Able to follow simple commands and cooperate with examinations Main outcome measure: Action Research Arm Test (ARAT), measuring UL motor function.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 120 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • First or recurrent ischemic or hemorrhagic stroke (diagnosis verified by CT or MR scan)
  • New upper limp impairment; Less than 15 days post stroke
  • ≥ 18 years
  • Able to follow simple commands and cooperate with examinations

排除标准

  • Subarachnoid hemorrhages
  • UL motor residuals from former stroke
  • Severe illness with life expectancy < 6 months
  • Place of residence more than 1½ hours drive away and not reachable for follow up assessments
  • Patients with contraindications for TMS are excluded from the TMS part of the study.

结局指标

主要结局

Action Research Arm test

时间窗: dec 2019

Upper limb function test

次要结局

  • Accellerometry(dec 2019)
  • Fugl Meyer Motor and sensory assesment(Dec 2019)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

招募中
2 期
Efficacy of Pre-operative Prehabilitation in Patients With Limb SarcomaSarcoma
NCT04515459Institut Claudius Regaud53
招募中
不适用
Evaluation of the Utility of Preanestes@s, a Web Based Application for Preoperative AssessmentMobile ApplicationsInternet-Based InterventionAmbulatory Surgical ProceduresPreoperative Period
NCT04787783Fundación Pública Andaluza para la gestión de la Investigación en Sevilla2,254
尚未招募
不适用
Phase II study on the feasibility and efficacy of consolidation with 90Y-ibritumomab tiuxetan in patients with relapsed or refractory aggressive B-cell non-Hodgkin’s lymphoma having achieved partial or complete remission after induction with R-PECC chemotherapy.Aggressive B-cell NHL: FL grade 3b and DLBC
NL-OMON24909Stichting Hemato-Oncologie voor Volwassenen Nederland (HOVON) P/a HOVON Data CenterErasmus MC - Daniel den HoedPostbus 52013008 AE RotterdamTel: 010 4391568Fax: 010 4391028e-mail: hdc@erasmusmc.nl60
招募中
不适用
Phase II study on the feasibility and efficacy of R-DHAP + HD-MTX, combined with intrathecal rituximab, followed by autologous stem cell transplantation in patients with a recurrent aggressive B-cell lymphoma with CNS localisation.Recurrent aggressive B-cell lymphoma with CNS localisation, DLBCL, non-hodgkin lymphoma, NH
NL-OMON23427Stichting Hemato-Oncologie voor Volwassenen Nederland (HOVON) P/a HOVON Data CenterErasmus MC - Daniel den HoedPostbus 52013008 AE RotterdamTel: 010 7041560Fax: 010 7041028e-mail: hdc@erasmusmc.nl35
已完成
不适用
Cost Efficacy of a Clinical Pathway to Patients Undergoing Hip and Knee Replacement SurgeryOsteoarthritis
NCT00175201University of Aarhus247
An Algorithm for Prognosis of Upper Limb Paresis in... | 临床试验